A detailed history of Meeder Asset Management Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Meeder Asset Management Inc holds 826 shares of CDXC stock, worth $5,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares
826
Previous 826 -0.0%
Holding current value
$5,071
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$5.42 - $7.08 $4,476 - $5,848
826 New
826 $5,000
Q3 2018

Nov 02, 2018

SELL
$3.5 - $4.91 $5,232 - $7,340
-1,495 Closed
0 $0
Q2 2018

Jul 24, 2018

BUY
$3.22 - $4.43 $4,813 - $6,622
1,495 New
1,495 $0
Q1 2018

May 03, 2018

SELL
$4.05 - $6.46 $1,020 - $1,627
-252 Closed
0 $0
Q4 2017

Feb 02, 2018

SELL
$3.88 - $6.96 $1,649 - $2,958
-425 Reduced 62.78%
252 $1,000
Q3 2017

Oct 20, 2017

BUY
$2.91 - $4.71 $1,970 - $3,188
677
677 $3,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $420M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.